Aducanumab: A Deep Dive into BIIB037 and its Impact This medication, previously known as BIIB037, is a notable endeavor to address emerging Alzheimer's disease. Created by Biogen, aducanumab functions by clearing https://www.targetmol.com/compound/aducanumab